Get real in individual participant data (IPD) meta-analysis: A review of the methodology

Research Synthesis Methods

Volumn 6, Issue 4, 2015, Pages 293-309

  Debray, Thomas P A ^a   Moons, Karel G M ^a   van Valkenhoef, Gert ^b   Efthimiou, Orestis ^c   Hummel, Noemi ^d   Groenwold, Rolf H H ^a   Reitsma, Johannes B ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF IOANNINA   (Greece)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cross design; Evidence synthesis; IPD; Meta analysis; Non randomized intervention studies; NRSI; RCT; Review

Indexed keywords

HUMAN; META ANALYSIS (TOPIC); PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOFTWARE; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

DATA INTERPRETATION, STATISTICAL; HUMANS; LINEAR MODELS; META-ANALYSIS AS TOPIC; MODELS, STATISTICAL; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOFTWARE; TREATMENT OUTCOME;

EID: 84956958671     PISSN: None     EISSN: 17592887     Source Type: Journal    
DOI: 10.1002/jrsm.1160     Document Type: Article

References (118)

1. Abo-Zaid GMA, Guo B, Deeks JJ, Debray TPA, Steyerberg EW, Moons KGM, Riley RD 2013. Individual participant data meta-analyses should not ignore clustering. Journal of Clinical Epidemiology 66: 865-873. DOI:10.1016/j.jclinepi.2012.12.017.
2. Ahmed I, Sutton AJ, Riley RD 2012. Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey. British Medical Journal 344: d7762. DOI:10.1136/bmj.d7762.
3. Ali S, Mealing S, Hawkins N, Lescrauwaet B, Bjork S, Mantovani L, Lampertico P 2013. The use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis b patients. BMJ Open 3: e001309. DOI:10.1136/bmjopen-2012-001309.
4. Barrett JK, Farewell VT, Siannis F, Tierney J, Higgins JPT 2012. Two-stage meta-analysis of survival data from individual participants using percentile ratios. Statistics in Medicine 31: 4296-4308. DOI:10.1002/sim.5516.
5. Berger ML, Martin BC, Husereau D, Worley K, Allen JD, Yang W, Quon NC, Mullins CD, Kahler KH, Crown W 2014. A questionnaire to assess the relevance and credibility of observational studies to inform health care decision making: an ISPOR-AMCP-NPC good practice task force report. Value in Health 17: 143-156. DOI:10.1016/j.jval.2013.12.011.
6. Berlin JA, Santanna J, Schmid CH, Szczech LA, Feldman HI, Anti-lymphocyte antibody induction therapy study group. 2002. Individual patient-versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Statistics in Medicine 21: 371-387. DOI: 10.1002/sim.1023.
7. Bowden J, Tierney JF, Simmonds M, Copas AJ, Higgins JP 2011. Individual patient data meta-analysis of time-to-event outcomes: one-stage versus two-stage approaches for estimating the hazard ratio under a random effects model. Research Synthesis Methods 2: 150-162. DOI:10.1002/jrsm.45.
8. Broström G, Holmberg H 2011. Generalized linear models with clustered data: fixed and random effects models. Computational Statistics & Data Analysis 55: 3123-3134. DOI:10.1016/j.csda.2011.06.011.
9. Bujkiewicz S, Thompson JR, Sutton AJ, Cooper NJ, Harrison MJ, Symmons DPM, Abrams KR 2014. Use of Bayesian multivariate meta-analysis to estimate the HAQ for mapping onto the EQ-5D questionnaire in rheumatoid arthritis. Value in Health 17: 109-115. DOI:10.1016/j.jval.2013.11.005.
10. Burdett S, Stewart LA 2002. A comparison of the results of checked versus unchecked individual patient data meta-analyses. International Journal of Technology Assessment in Health Care 18: 619-624.
11. Burgess S, White IR, Resche-Rigon M, Wood AM 2013. Combining multiple imputation and meta-analysis with individual participant data. Statistics in Medicine 32: 4499-4514. DOI:10.1002/sim.5844.
12. Buyse M, Piedbois P 1996. On the relationship between response to treatment and survival time. Statistics in Medicine 15: 2797-2812. DOI:10.1002/(SICI)1097-0258(19961230)15:24<2797::AID-SIM290>3.0.CO;2-V.
13. Clarke M, Godwin J 1998. Systematic reviews using individual patient data: a map for the minefields? Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 9: 827-833. DOI:10.1023/A:1008468705492.
14. Clarke MJ, Stewart LA 1994. Obtaining data from randomised controlled trials: how much do we need for reliable and informative meta-analyses? British Medical Journal 309: 1007-1010. DOI:10.1136/bmj.309.6960.1007.
15. Concato J, Shah N, Horwitz RI 2000. Randomized, controlled trials, observational studies, and the hierarchy of research designs. New England Journal of Medicine 342: 1887-1892. DOI:10.1056/NEJM200006223422507.
16. Crowther MJ, Riley RD, Staessen JA, Wang J, Gueyffier F, Lambert PC 2012. Individual patient data meta-analysis of survival data using Poisson regression models. BMC Medical Research Methodology 12: 34. DOI:10.1186/1471-2288-12-34.
17. Debray TPA, Moons KGM, Abo-Zaid GMA, Koffijberg H, Riley RD 2013. Individual participant data meta-analysis for a binary outcome: one-stage or two-stage? PLoS One 8: e60650. DOI:10.1371/journal.pone.0060650.
18. Donders ART, van der Heijden GJMG, Stijnen T, Moons KGM 2006. Review: a gentle introduction to imputation of missing values. Journal of Clinical Epidemiology 59: 1087-1091. DOI:10.1016/j.jclinepi.2006.01.014.
19. Donegan S, Williamson P, D'Alessandro U, Garner P, Smith CT 2013. Combining individual patient data and aggregate data in mixed treatment comparison meta-analysis: individual patient data may be beneficial if only for a subset of trials. Statistics in Medicine 32: 914-030. DOI:10.1002/sim.5584.
20. Donegan S, Williamson P, D'Alessandro U, Tudur Smith C 2012. Assessing the consistency assumption by exploring treatment by covariate interactions in mixed treatment comparison meta-analysis: individual patient-level covariates versus aggregate trial-level covariates. Statistics in Medicine 31: 3840-3857. DOI:10.1002/sim.5470.
21. Droitcour J, Silberman G, Chelimsky E 1993. A new form of meta-analysis for combining results from randomized clinical trials and medical-practice databases. International Journal of Technology Assessment in Health Care 9: 440-449. DOI:10.1017/S0266462300004694.
22. Duchateau L, Pignon JP, Bijnens L, Bertin S, Bourhis J, Sylvester R 2001. Individual patient-versus literature-based meta-analysis of survival data: time to event and event rate at a particular time can make a di_erence, an example based on head and neck cancer. Controlled Clinical Trials 22: 538-547. DOI:10.1016/S0197-2456(01)00152-0.
23. Efthimiou O, Debray TPA, van Valkenhoef G, Trelle S, Panayidou K, Moons KGM, Reitsma JB, Shang A, Salanti G, on behalf of the GetReal methods review group. 2015. Methods for network meta-analysis: a review. Research Synthesis Methods submitted.
24. Fisher DJ, Copas AJ, Tierney JF, Parmar MKB 2011. A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners. Journal of Clinical Epidemiology 64: 949-967. DOI:10.1016/j.jclinepi.2010.11.016.
25. Golder S, Loke YK, Bland M 2011. Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview. PLoS Medicine 8: e1001026. DOI:10.1371/journal.pmed.1001026.
26. Goldstein H, Browne W, Rasbash J 2002. Multilevel modelling of medical data. Statistics in Medicine 21: 3291-3315. DOI:10.1002/sim.1264.
27. Goldstein H, Yang M, Omar R, Turner R, Thompson S 2000. Meta-analysis using multilevel models with an application to the study of class size e_ects. Journal of the Royal Statistical Society: Series C: Applied Statistics 49: 399-412. DOI:10.1111/1467-9876.00200.
28. Guyot P, Ades AE, Ouwens MJNM, Welton NJ 2012. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Medical Research Methodology 12: 9. DOI:10.1186/1471-2288-12-9.
29. Haines TP, Hill AM 2011. Inconsistent results in meta-analyses for the prevention of falls are found between study-level data and patient-level data. Journal of Clinical Epidemiology 64: 154-162. DOI:10.1016/j.jclinepi.2010.04.024.
30. Hall DB 2000. Zero-inflated Poisson and binomial regression with random effects: a case study. Biometrics 56: 1030-1039.
31. Higgins JP, Ramsay C, Reeves BC, Deeks JJ, Shea B, Valentine JC, Tugwell P, Wells G 2013. Issues relating to study design and risk of bias when including non-randomized studies in systematic reviews on the effects of interventions. Research Synthesis Methods 4: 12-25. DOI:10.1002/jrsm.1056.
32. Higgins JPT, Whitehead A, Turner RM, Omar RZ, Thompson SG 2001. Meta-analysis of continuous outcome data from individual patients. Statistics in Medicine 20: 2219-2241. DOI:10.1002/sim.918.
33. Ioannidis JP, Haidich AB, Pappa M, Pantazis N, Kokori SI, Tektonidou MG, Contopoulos-Ioannidis DG, Lau J 2001. Comparison of evidence of treatment effects in randomized and nonrandomized studies. Journal of the American Medical Association 286: 821-830. DOI:10.1001/jama.286.7.821.
34. Jackson C, Best N, Richardson S 2006. Improving ecological inference using individual-level data. Statistics in Medicine 25: 2136-2159. DOI:10.1002/sim.2370.
35. Jackson C, Best N, Richardson S 2008. Hierarchical related regression for combining aggregate and individual data in studies of socio-economic disease risk factors. Journal of the Royal Statistical Society: Series A (Statistics in Society) 171: 159-178. DOI:10.1111/j.1467-985X.2007.00500.x.
36. Jansen JP 2012. Network meta-analysis of individual and aggregate level data. Research Synthesis Methods 3: 177-190. DOI:10.1002/jrsm.1048.
37. Jansen JP, Trikalinos T, Cappelleri JC, Daw J, Andes S, Eldessouki R, Salanti G 2014. Indirect treatment comparison/network meta-analysis study questionnaire to assess relevance and credibility to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report. Value in Health 17: 157-173. DOI:10.1016/j.jval.2014.01.004.
38. Jolani S, Debray TPA, Koffijberg H, van Buuren S, Moons KGM 2015. Imputation of systematically missing predictors in an individual participant data meta-analysis: a generalized approach using MICE. Statistics in Medicine 34: 1841-1863. DOI:10.1002/sim.6451.
39. Jones AP, Riley RD, Williamson PR, Whitehead A 2009. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials. Clinical Trials 6: 16-27. DOI:10.1177/1740774508100984.
40. Kaizar EE 2011. Estimating treatment effect via simple cross design synthesis. Statistics in Medicine 30: 2986-3009. DOI:10.1002/sim.4339.
41. Katsahian S, Latouche A, Mary JY, Chevret S, Porcher R 2008. Practical methodology of meta-analysis of individual patient data using a survival outcome. Contemporary Clinical Trials 29: 220-230. DOI:10.1016/j.cct.2007.08.002.
42. Kim S, Chen MH, Ibrahim JG, Shah AK, Lin J 2013. Bayesian inference for multivariate meta-analysis Box-Cox transformation models for individual patient data with applications to evaluation of cholesterol-lowering drugs. Statistics in Medicine 32: 39723990.
43. Koopman L, van der Heijden GJMG, Glasziou PP, Grobbee DE, Rovers MM 2007. A systematic review of analytical methods used to study subgroups in (individual patient data) meta-analyses. Journal of Clinical Epidemiology 60: 1002-1009. DOI:10.1016/j.jclinepi.2007.01.018.
44. Koopman L, van der Heijden GJMG, Grobbee DE, Rovers MM 2008a. Comparison of methods of handling missing data in individual patient data meta-analyses: an empirical example on antibiotics in children with acute otitis media. American Journal of Epidemiology 167: 540-545. DOI:10.1093/aje/kwm341.
45. Koopman L, van der Heijden GJMG, Hoes AW, Grobbee DE, Rovers MM 2008b. Empirical comparison of subgroup effects in conventional and individual patient data meta-analyses. International Journal of Technological Assessment in Health Care 24: 358-361. DOI:10.1017/S0266462308080471.
46. Lambert PC, Sutton AJ, Abrams KR, Jones DR 2002. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. Journal of Clinical Epidemiology 55: 86-94. DOI:10.1016/S0895-4356(01)00414-0.
47. Larose DT, Dey DK 1997. Grouped random effects models for Bayesian meta-analysis. Statistics in Medicine 16: 1817-1829. DOI:10.1002/(SICI)1097-0258(19970830)16:16<1817::AID-SIM621>3.0.CO;2-N.
48. Lau J, Ioannidis JP, Schmid CH 1998. Summing up evidence: one answer is not always enough. Lancet 351: 123-127. DOI:10.1016/S0140-6736(97)08468-7.
49. Lee AH, Wang K, Scott JA, Yau KKW, McLachlan GJ 2006. Multi-level zero-innated Poisson regression modelling of correlated count data with excess zeros. Statistical Methods in Medical Research 15: 47-61.
50. Li B, Lingsma HF, Steyerberg EW, Lesaffre E 2011. Logistic random effects regression models: a comparison of statistical packages for binary and ordinal outcomes. BMC Medical Research Methodology 11: 77. DOI:10.1186/1471-2288-11-77.
51. Li Z, Begg B 1994. Random effects models for combining results from controlled and uncontrolled studies in a meta-analysis. Journal of the American Statistical Association 89: 1523-1527. DOI:10.2307/2291015.
52. Li Z, Meredith MP 2003. Exploring the relationship between surrogates and clinical outcomes: analysis of individual patient data vs. meta-regression on group-level summary statistics. Journal of Biopharmaceutical Statistics 13: 777-792. DOI:10.1081/BIP-120024209.
53. Lilford RJ, Richardson A, Stevens A, Fitzpatrick R, Edwards S, Rock F, Hutton JL 2001. Issues in methodological research: perspectives from researchers and commissioners. Health Technology Assessment 5: 1-57.
54. Lyman GH, Kuderer NM 2005. The strengths and limitations of meta-analyses based on aggregate data. BMC Medical Research Methodology 5: 14. DOI:10.1186/1471-2288-5-14.
55. Mathew T, Nordström K 2010. Comparison of one-step and two-step meta-analysis models using individual patient data. Biometrical Journal 52: 271-287. DOI:10.1002/bimj.200900143.
56. Michiels S, Baujat B, Mahé C, Sargent D, Pignon J 2005. Random effects survival models gave a better understanding of heterogeneity in individual patient data meta-analyses. Journal of Clinical Epidemiology 58: 238-245. DOI:10.1016/j.jclinepi.2004.08.013.
57. Peters JL, Rushton L, Sutton AJ, Jones DR, Abrams KR, Mugglestone MA 2005. Bayesian methods for the cross-design synthesis of epidemiological and toxicological evidence. Journal of the Royal Statistical Society: Series C: Applied Statistics 54: 159-172. DOI:10.1111/j.1467-9876.2005.00476.x.
58. Piepho HP, Williams ER, Madden LV 2012. The use of two-way linear mixed models in multitreatment meta-analysis. Biometrics 68: 1269-1277. DOI:10.1111/j.1541-0420.2012.01786.x.
59. Poppe K, Doughty R, Yu C, Quintana M, Møller J, Klein A, Gamble G, Dini F, Whalley G, MeRGE collaborators 2011. Understanding differences in results from literature-based and individual patient meta-analyses: an example from meta-analyses of observational data. International Journal of Cardiology 148: 209-213. DOI:10.1016/j.ijcard.2009.09.566.
60. Prevost TC, Abrams KR, Jones DR 2000. Hierarchical models in generalized synthesis of evidence: an example based on studies of breast cancer screening. Statistics in Medicine 19: 3359-3376. DOI:10.1002/1097-0258(20001230)19:24<3359::AID-SIM710>3.0.CO;2-N.
61. Ravva P, Karlsson MO, French JL 2014. A linearization approach for the model-based analysis of combined aggregate and individual patient data. Statistics in Medicine 33: 1460-1476. DOI:10.1002/sim.6045.
62. Reeves BC, Higgins JPT, Ramsay C, Shea B, Tugwell P, Wells GA 2003. An introduction to methodological issues when including non-randomised studies in systematic reviews on the effects of interventions. Research Synthesis Methods 4: 1-11. DOI:10.1002/jrsm.1068.
63. Resche-Rigon M, White IR, Bartlett JW, Peters SAE, Thompson SG 2013. Multiple imputation for handling systematically missing confounders in meta-analysis of individual participant data. Statistics in Medicine 32: 4890-4905. DOI:10.1002/sim.5894.
64. Riley RD, Kauser I, Bland M, Thijs L, Staessen JA, Wang J, Gueyffier F, Deeks JJ 2013. Meta-analysis of randomised trials with a continuous outcome according to baseline imbalance and availability of individual participant data. Statistics in Medicine 32: 2747-2766. DOI:10.1002/sim.5726.
65. Riley RD, Lambert PC, Abo-Zaid G 2010. Meta-analysis of individual participant data: rationale, conduct, and reporting. British Medical Journal 340: c221. DOI:10.1136/bmj.c221.
66. Riley RD, Lambert PC, Staessen JA, Wang J, Gueyffier F, Thijs L, Boutitie F 2008. Meta-analysis of continuous outcomes combining individual patient data and aggregate data. Statistics in Medicine 27: 1870-1893. DOI:10.1002/sim.3165.
67. Riley RD, Simmonds MC, Look MP 2007. Evidence synthesis combining individual patient data and aggregate data: a systematic review identi_ed current practice and possible methods. Journal of Clinical Epidemiology 60: 431-439. DOI:10.1016/j.jclinepi.2006.09.009.
68. Riley RD, Steyerberg EW 2010. Meta-analysis of a binary outcome using individual participant data and aggregate data. Research Synthesis Methods 1: 2-19. DOI:10.1002/jrsm.4.
69. Rondeau V, Michiels S, Liquet B, Pignon JP 2008. Investigating trial and treatment heterogeneity in an individual patient data meta-analysis of survival data by means of the penalized maximum likelihood approach. Statistics in Medicine 27: 1894-1910. DOI:10.1002/sim.3161.
70. Royston P, Parmar MKB 2002. Flexible parametric proportional-hazards and proportional odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Statistics in Medicine 21: 2175-2197. DOI:10.1002/sim.1203.
71. Royston P, Sauerbrei W 2004. A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials. Statistics in Medicine 23: 2509-2525. PMID: 15287081.
72. Rubin DB. 1987. Multiple Imputation for Nonresponse in Surveys. John Wiley and Sons, New York.
73. Saramago P, Sutton AJ, Cooper NJ, Manca A 2012. Mixed treatment comparisons using aggregate and individual participant level data. Statistics in Medicine 31: 3516-3536. DOI:10.1002/sim.5442.
74. Sargent DJ 1998. A general framework for random effects survival analysis in the Cox proportional hazards setting. Biometrics 54: 1486-1497.
75. Schafer JL 1999. Multiple imputation: a primer. Statistical Methods in Medical Research 8: 3-15. DOI:10.1177/096228029900800102.
76. Schmid CH, Stark PC, Berlin JA, Landais P, Lau J 2004. Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. Journal of Clinical Epidemiology 57: 683-697. DOI:10.1016/j.jclinepi.2003.12.001.
77. Schmidt AF, Rovers MM, Klungel OH, Hoes AW, Knol MJ, Nielen M, de Boer A, Groenwold RHH 2013. Differences in interaction and subgroup-specific effects were observed between randomized and nonrandomized studies in three empirical examples. Journal of Clinical Epidemiology 66: 599-607. DOI:10.1016/j.jclinepi.2012.08.008.
78. Siannis F, Barrett J, Farewell V, Tierney J 2010. One-stage parametric meta-analysis of time-to-event outcomes. Statistics in Medicine 29: 3030-3045. DOI:10.1002/sim.4086.
79. Signorovitch JE, Sikirica V, Erder MH, Xie J, Lu M, Hodgkins PS, Betts KA, Wu EQ 2012. Matching-adjusted indirect comparisons: a new tool for timely comparative effectiveness research. Value in Health 15: 940-947. DOI:10.1016/j.jval.2012.05.004.
80. Signorovitch JE, Wu EQ, Yu AP, Gerrits CM, Kantor E, Bao Y, Gupta SR, Mulani PM 2010. Comparative effectiveness without head-to-head trials: a method for matching adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanercept. PharmacoEconomics 28: 935-945. DOI:10.2165/11538370-000000000-00000.
81. Simmonds MC, Higgins JPT 2007. Covariate heterogeneity in meta-analysis: criteria for deciding between meta-regression and individual patient data. Statistics in Medicine 26: 2982-2999. DOI:10.1002/sim.2768.
82. Simmonds MC, Higgins JPT, Stewart LA, Tierney JF, Clarke MJ, Thompson SG 2005. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clinical Trials 2: 209-217. DOI:10.1191/1740774505cn087oa.
83. Steinberg KK, Smith SJ, Stroup DF, Olkin I, Lee NC, Williamson GD, Thacker SB 1997. Comparison of effect estimates from a meta-analysis of summary data from published studies and from a meta-analysis using individual patient data for ovarian cancer studies. American Journal of Epidemiology 145: 917-925.
84. Stewart GB, Altman DD, Askie L, Duley L, Simmonds M, Stewart LA 2012. Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice. PLoS One 7: e46042. DOI:10.1371/journal.pone.0046042.
85. Stewart LA, Tierney JF 2002. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Evaluation & the Health Professions 25: 76-97. DOI:10.1177/0163278702025001006.
86. Stijnen T, Hamza TH, Özdemir P 2010. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Statistics in Medicine 29: 3046-3067. DOI:10.1002/sim.4040.
87. Stuart EA, Cole SR, Bradshaw CP, Leaf PJ 2011. The use of propensity scores to assess the generalizability of results from randomized trials: use of propensity scores to assess generalizability. Journal of the Royal Statistical Society: Series A (Statistics in Society) 174: 369-386. DOI:10.1111/j.1467-985X.2010.00673.x.
88. Sud S, Douketis J 2009. The devil is in the details...or not? A primer on individual patient data meta-analysis. Evidence-Based Medicine 14: 100-101. DOI:10.1136/ebm.14.4.100.
89. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F 1998. Systematic reviews of trials and other studies. Health Technology Assessment 2: 1-276. DOI:10.3310/hta2190.
90. Sutton AJ, Cooper NJ, Jones DR 2009. Evidence synthesis as the key to more coherent and efficient research. BMC Medical Research Methodology 9: 29. DOI:10.1186/1471-2288-9-29.
91. Sutton AJ, Higgins JPT 2008. Recent developments in meta-analysis. Statistics in Medicine 27: 625-650. DOI:10.1002/sim.2934.
92. Sutton AJ, Kendrick D, Coupland C 2008. Meta-analysis of individual- and aggregate-level data. Statistics in Medicine 27: 651-669. DOI:10.1002/sim.2916.
93. Teramukai S, Matsuyama Y, Mizuno S, Sakamoto J 2004. Individual patient-level and study-level meta-analysis for investigating modifiers of treatment effect. Japanese Journal of Clinical Oncology 34: 717-721. DOI:10.1093/jjco/hyh138.
94. Thomas D, Radji S, Benedetti A 2014. Systematic review of methods for individual patient data meta-analysis with binary outcomes. BMC Medical Research Methodology 14: 79. DOI:10.1186/1471-2288-14-79.
95. Thompson A 2009. Thinking big: large-scale collaborative research in observational epidemiology. European Journal of Epidemiology 24: 727-731. DOI:10.1007/s10654-009-9412-1.
96. Thompson S, Kaptoge S, White I, Wood A, Perry P, Danesh J, The Emerging Risk Factors Collaboration 2010. Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies. International Journal of Epidemiology 39: 1345-1359. DOI:10.1093/ije/dyq063.
97. Thompson SG, Turner RM, Warn DE 2001. Multilevel models for meta-analysis, and their application to absolute risk differences. Statistical Methods in Medical Research 10: 375-392. DOI:10.1177/096228020101000602.
98. Tierney JF, Stewart LA 2005. Investigating patient exclusion bias in meta-analysis. International Journal of Epidemiology 34: 79-87. DOI:10.1093/ije/dyh300.
99. Tobías A, Saez M, Kogevinas M 2004. Meta-analysis of results and individual patient data in epidemiological studies. Journal of Modern Applied Statistical Methods 3: 176-185.
100. Trikalinos TA, Ioannidis JP 2001. Predictive modeling and heterogeneity of baseline risk in meta-analysis of individual patient data. Journal of Clinical Epidemiology 54: 245-252. DOI:10.1016/S0895-4356(00)00311-5.
101. Tudur Smith C, Williamson PR 2007. A comparison of methods for fixed effects meta-analysis of individual patient data with time to event outcomes. Clinical Trials 4: 621-630. DOI:10.1177/1740774507085276.
102. Tudur Smith C, Williamson PR, Marson AG 2005a. Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes. Statistics in Medicine 24: 1307-1319. DOI:10.1002/sim.2050.
103. Tudur Smith C, Williamson PR, Marson AG 2005b. An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes. Journal of Evaluation in Clinical Practice 11: 468-478. DOI:10.1111/j.1365-2753.2005.00559.x.
104. Turner RM, Omar RZ, Yang M, Goldstein H, Thompson SG 2000. A multilevel model framework for meta-analysis of clinical trials with binary outcomes. Statistics in Medicine 19: 3417-3432. DOI:10.1002/1097-0258(20001230)19:24<3417::AID-SIM614>3.0.CO;2-L.
105. Vaida F, Xu R 2000. Proportional hazards model with random effects. Statistics in Medicine 19: 3309-3324. DOI:10.1002/1097-0258(20001230)19:24<3309::AID-SIM825>3.0.CO;2-9.
106. Valentine JC, Thompson SG 2013. Issues relating to confounding and meta-analysis when including non-randomized studies in systematic reviews on the effects of interventions. Research Synthesis Methods 4: 26-35. DOI:10.1002/jrsm.1064.
107. Viele K, Berry S, Neuenschwander B, Amzal B, Chen F, Enas N, Hobbs B, Ibrahim JG, Kinnersley N, Lindborg S, Micallef S, Roychoudhury S, Thompson L 2014. Use of historical control data for assessing treatment effects in clinical trials. Pharmaceutical Statistics 13: 41-54. DOI:10.1002/pst.1589.
108. Wakefield J, Salway R 2001. A statistical framework for ecological and aggregate studies. Journal of the Royal Statistical Society: Series A (Statistics in Society) 164: 119-137.
109. van Walraven C 2010. Individual patient meta-analysis - rewards and challenges. Journal of Clinical Epidemiology 63: 235-237. DOI:10.1016/j.jclinepi.2009.04.001.
110. Wells GA, Shea B, Higgins JP, Sterne J, Tugwell P, Reeves BC 2013. Checklists of methodological issues for review authors to consider when including non-randomized studies in systematic reviews. Research Synthesis Methods 4: 63-77. DOI:10.1002/jrsm.1077.
111. White IR, Welton NJ, Wood AM, Ades AE, Higgins JPT 2008. Allowing for uncertainty due to missing data in meta-analysis-part 2: hierarchical models. Statistics in Medicine 27: 728-745. DOI:10.1002/sim.3007.
112. Whitehead A, Omar RZ, Higgins JP, Savaluny E, Turner RM, Thompson SG 2001. Meta-analysis of ordinal outcomes using individual patient data. Statistics in Medicine 20: 2243-2260. DOI:10.1002/sim.919.
113. Yamaguchi T, Ohashi Y 1999. Investigating centre effects in a multi-centre clinical trial of superficial bladder cancer. Statistics in Medicine 18: 1961-1971.
114. Yamaguchi T, Ohashi Y, Matsuyama Y 2002. Proportional hazards models with random effects to examine centre effects in multicentre cancer clinical trials. Statistical Methods in Medical Research 11: 221-236. DOI:10.1191/0962280202sm284ra.
115. Yau KK, Lee AH 2001. Zero-inflated Poisson regression with random effects to evaluate an occupational injury prevention programme. Statistics in Medicine 20: 2907-2920. DOI:10.1002/sim.860.
116. Yau KK, McGilchrist CA 1998. ML and REML estimation in survival analysis with time dependent correlated frailty. Statistics in Medicine 17: 1201-1213. DOI:10.1002/(SICI)1097-0258(19980615)17:11<1201::AID-SIM845>3.0.CO;2-7.
117. Yucel RM 2008. Multiple imputation inference for multivariate multilevel continuous data with ignorable non-response. Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences 366: 2389-2403. DOI:10.1098/rsta.2008.0038.
118. Yucel RM 2011. Random-covariances and mixed-effects models for imputing multivariate multilevel continuous data. Statistical Modelling 11: 351-370. DOI:10.1177/1471082X1001100404.